We provide you with 20 years of free, institutional-grade data for ALEC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ALEC. Explore the full financial landscape of ALEC stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-08-07 | 1653087 | ALEC | 10-Q | Url |
| 2025-05-08 | 1653087 | ALEC | 10-Q | Url |
| 2025-02-26 | 1653087 | ALEC | 10-K | Url |
| 2024-11-06 | 1653087 | ALEC | 10-Q | Url |
| 2024-08-07 | 1653087 | ALEC | 10-Q | Url |
| 2024-05-08 | 1653087 | ALEC | 10-Q | Url |
| 2024-02-27 | 1653087 | ALEC | 10-K | Url |
| 2023-11-07 | 1653087 | ALEC | 10-Q | Url |
| 2023-08-03 | 1653087 | ALEC | 10-Q | Url |
| 2023-05-04 | 1653087 | ALEC | 10-Q | Url |
| 2023-02-28 | 1653087 | ALEC | 10-K | Url |
| 2022-11-08 | 1653087 | ALEC | 10-Q | Url |
| 2022-08-04 | 1653087 | ALEC | 10-Q | Url |
| 2022-05-05 | 1653087 | ALEC | 10-Q | Url |
| 2022-02-24 | 1653087 | ALEC | 10-K | Url |
| 2021-11-04 | 1653087 | ALEC | 10-Q | Url |
| 2021-08-03 | 1653087 | ALEC | 10-Q | Url |
| 2021-05-05 | 1653087 | ALEC | 10-Q | Url |
| 2021-02-25 | 1653087 | ALEC | 10-K | Url |
| 2020-11-10 | 1653087 | ALEC | 10-Q | Url |
| 2020-08-11 | 1653087 | ALEC | 10-Q | Url |
| 2020-05-13 | 1653087 | ALEC | 10-Q | Url |
| 2020-03-24 | 1653087 | ALEC | 10-K | Url |
| 2020-01-27 | 1653087 | ALEC | S-1 | Url |
| 2019-11-12 | 1653087 | ALEC | 10-Q | Url |
| 2019-08-12 | 1653087 | ALEC | 10-Q | Url |
| 2019-05-13 | 1653087 | ALEC | 10-Q | Url |
| 2019-03-26 | 1653087 | ALEC | 10-K | Url |
| 2019-01-07 | 1653087 | ALEC | S-1 | Url |
Alector, Inc(NASDAQ:ALEC) 
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Park...
Website: http://alector.com
Founded: 2013
Full Time Employees: 162
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ALEC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.